111 related articles for article (PubMed ID: 2376925)
1. [Establishment of a model to evaluate inhibition of bone resorption induced by bladder tumor (MBT-2) in mice].
Nishijima Y; Nemoto R; Koiso K
Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):694-700. PubMed ID: 2376925
[TBL] [Abstract][Full Text] [Related]
2. A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium.
Nemoto R; Uchida K; Tsutsumi M; Koiso K; Satou S; Satou T
J Cancer Res Clin Oncol; 1987; 113(6):539-43. PubMed ID: 3119600
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice.
Nemoto R; Satou S; Miyagawa I; Koiso K
Cancer; 1991 Feb; 67(3):643-8. PubMed ID: 1898709
[TBL] [Abstract][Full Text] [Related]
4. Response of MBT-2 bladder carcinoma-induced osteolysis to various agents.
Nemoto R; Satou S; Mochizuki T; Okabe K
Cancer; 1992 May; 69(9):2316-21. PubMed ID: 1562978
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice.
Nemoto R; Sato S; Nishijima Y; Miyakawa I; Koiso K; Harada M
J Urol; 1990 Sep; 144(3):770-4. PubMed ID: 2117674
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.
Nemoto R; Nishijima Y; Uchida K; Koiso K
Br J Cancer; 1993 May; 67(5):893-7. PubMed ID: 8494721
[TBL] [Abstract][Full Text] [Related]
7. Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice.
Clohisy DR; O' Keefe PF; Ramnaraine ML
J Orthop Res; 2001 Jul; 19(4):554-8. PubMed ID: 11518261
[TBL] [Abstract][Full Text] [Related]
8. Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorbing activity in an experimental animal model.
Hiraga T; Takada M; Nakajima T; Ozawa H
J Oral Maxillofac Surg; 1996 Nov; 54(11):1327-33. PubMed ID: 8941184
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a model to evaluate inhibition of bone resorption induced by human prostate cancer cells in nude mice.
Nemoto R; Kanoh S; Koiso K; Harada M
J Urol; 1988 Oct; 140(4):875-9. PubMed ID: 3138435
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
[TBL] [Abstract][Full Text] [Related]
11. Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice.
Sasaki A; Kitamura K; Alcalde RE; Tanaka T; Suzuki A; Etoh Y; Matsumura T
Int J Cancer; 1998 Jul; 77(2):279-85. PubMed ID: 9650565
[TBL] [Abstract][Full Text] [Related]
12. Bone resorption induced by transplanted bladder tumor (MBT-2) in mice.
Nemoto R; Uchida K; Tsutsumi M; Koiso K; Satoh T
J Urol; 1988 Mar; 139(3):650-2. PubMed ID: 3343758
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
Body JJ; Dumon JC; Gineyts E; Delmas PD
Br J Cancer; 1997; 75(3):408-12. PubMed ID: 9020487
[TBL] [Abstract][Full Text] [Related]
14. Local bone resorption induced by serially transplantable human renal cell carcinoma in nude mice.
Nemoto R; Kanoh S; Koiso K; Shigenori S; Kabashima T; Haebara H
Urol Int; 1987; 42(5):326-9. PubMed ID: 3433578
[TBL] [Abstract][Full Text] [Related]
15. [Anti-osteolytic therapy preserves trabecular structure and mechanical properties of bone in tumor osteolysis].
Kurth AA; Kim SZ; Bauss F; Müller R; Hovy L
Z Orthop Ihre Grenzgeb; 2000; 138(2):146-51. PubMed ID: 10820881
[TBL] [Abstract][Full Text] [Related]
16. Morphology of bone metastasis.
Hiraga T; Tanaka S; Ikegame M; Koizumi M; Iguchi H; Nakajima T; Ozawa H
Eur J Cancer; 1998 Feb; 34(2):230-9. PubMed ID: 9741326
[No Abstract] [Full Text] [Related]
17. Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.
Clarke NW; McClure J; George NJ
Br J Urol; 1992 Jan; 69(1):64-70. PubMed ID: 1737255
[TBL] [Abstract][Full Text] [Related]
18. Treating bone metastases: sparing the patient needless pain.
McBride G
J Natl Cancer Inst; 1997 Mar; 89(6):418-9. PubMed ID: 9091642
[No Abstract] [Full Text] [Related]
19. Diphosphonates for osteolytic metastases.
Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
Lancet; 1985 May; 1(8438):1155-6. PubMed ID: 2860356
[No Abstract] [Full Text] [Related]
20. Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients.
Theriault R
Br J Clin Pract Suppl; 1996 Sep; 87():8-12; discussion 13-4. PubMed ID: 8995011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
